Natus Medical Incorporated (NTUS) Financial Statements (2025 and earlier)
Company Profile
| Business Address |
3150 PLEASANT VIEW ROAD MIDDLETON, WI 53562 |
| State of Incorp. | DE |
| Fiscal Year End | December 31 |
| Industry (SIC) | 3845 - Electromedical and Electrotherapeutic Apparatus (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)Annual | Quarterly
| 3/31/2022 Q1 | 12/31/2021 Q4 | 9/30/2021 Q3 | 6/30/2021 Q2 | 3/31/2021 Q1 | 12/31/2020 Q4 | 9/30/2020 Q3 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 75,595 | 68,779 | 62,494 | 80,549 | 82,082 | 74,536 | |||
| Cash and cash equivalent | 75,595 | 68,779 | 62,494 | 80,549 | 82,082 | 74,536 | |||
| Net investment in lease, before allowance for credit loss | 447 | 444 | |||||||
| Receivables | 111,760 | 97,370 | 92,793 | 91,326 | 93,133 | 84,107 | |||
| Inventory, net of allowances, customer advances and progress billings | 67,745 | 71,545 | 68,350 | 69,467 | 75,650 | 80,135 | |||
| Inventory | 67,745 | 71,545 | 68,350 | 69,467 | 75,650 | 80,135 | |||
| Other undisclosed current assets | 21,744 | 23,977 | 22,062 | 24,477 | 20,393 | 27,740 | |||
| Total current assets: | 277,291 | 261,671 | 245,699 | 265,819 | 271,702 | 266,518 | |||
| Noncurrent Assets | |||||||||
| Operating lease, right-of-use asset | 9,288 | 9,946 | 10,946 | 10,776 | 11,669 | 11,960 | |||
| Property, plant and equipment | 21,783 | 22,837 | 23,552 | 23,282 | 24,516 | 24,245 | |||
| Intangible assets, net (including goodwill) | 214,170 | 222,895 | 230,536 | 234,762 | 244,040 | 241,746 | |||
| Goodwill | 148,657 | 149,293 | 150,482 | 149,761 | 151,299 | 147,716 | |||
| Intangible assets, net (excluding goodwill) | 65,513 | 73,602 | 80,054 | 85,001 | 92,741 | 94,030 | |||
| Deferred income tax assets | 23,161 | 26,296 | 26,349 | 26,321 | 27,563 | 28,749 | |||
| Other noncurrent assets | 18,595 | 17,606 | 19,136 | 20,408 | 20,904 | 23,672 | |||
| Total noncurrent assets: | 286,997 | 299,580 | 310,519 | 315,549 | 328,692 | 330,372 | |||
| TOTAL ASSETS: | 564,288 | 561,251 | 556,218 | 581,368 | 600,394 | 596,890 | |||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities | 84,540 | 72,897 | 72,145 | 70,278 | 67,665 | 66,631 | |||
| Accounts payable | 36,405 | 28,322 | 26,892 | 24,486 | 23,429 | 27,597 | |||
| Accrued liabilities | 48,135 | 44,575 | 45,253 | 45,792 | 44,236 | 39,034 | |||
| Deferred revenue | 25,097 | 25,737 | 24,465 | 23,669 | 21,308 | 20,034 | |||
| Debt | 231 | 36,523 | 50,414 | 40,000 | |||||
| Other undisclosed current liabilities | 4,733 | 5,167 | 5,853 | 6,006 | 6,365 | 5,343 | |||
| Total current liabilities: | 114,601 | 103,801 | 102,463 | 136,476 | 145,752 | 132,008 | |||
| Noncurrent Liabilities | |||||||||
| Long-term debt and lease obligation | 6,567 | 7,370 | 8,061 | 8,181 | 14,799 | 35,055 | |||
| Long-term debt, excluding current maturities | 5,840 | 25,697 | |||||||
| Liabilities, other than long-term debt | 18,370 | 27,558 | 27,867 | 27,779 | 28,749 | 34,360 | |||
| Deferred income tax liabilities | 1,133 | 9,826 | 10,038 | 9,915 | 10,298 | 14,786 | |||
| Other liabilities | 17,237 | 17,732 | 17,829 | 17,864 | 18,451 | 19,574 | |||
| Operating lease, liability | 6,567 | 7,370 | 8,061 | 8,181 | 8,959 | 9,358 | |||
| Total noncurrent liabilities: | 24,937 | 34,928 | 35,928 | 35,960 | 43,548 | 69,415 | |||
| Total liabilities: | 139,538 | 138,729 | 138,391 | 172,436 | 189,300 | 201,423 | |||
| Equity | |||||||||
| Equity, attributable to parent | 424,750 | 422,522 | 417,827 | 408,932 | 411,094 | 395,467 | |||
| Common stock | 353,737 | 350,457 | 347,818 | 344,696 | 342,828 | 339,665 | |||
| Accumulated other comprehensive loss | (13,473) | (10,677) | (7,160) | (9,469) | (3,043) | (10,304) | |||
| Retained earnings | 84,486 | 82,742 | 77,169 | 73,705 | 71,309 | 66,106 | |||
| Total equity: | 424,750 | 422,522 | 417,827 | 408,932 | 411,094 | 395,467 | |||
| TOTAL LIABILITIES AND EQUITY: | 564,288 | 561,251 | 556,218 | 581,368 | 600,394 | 596,890 | |||
Income Statement (P&L) ($ in thousands)Annual | Quarterly
| 3/31/2022 Q1 | 12/31/2021 Q4 | 9/30/2021 Q3 | 6/30/2021 Q2 | 3/31/2021 Q1 | 12/31/2020 Q4 | 9/30/2020 Q3 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 128,656 | 113,877 | 115,978 | 114,927 | 118,718 | 102,803 | ||
| Market data revenue | 113,877 | 115,978 | 114,927 | 102,803 | ||||
| Other undisclosed gross profit | (55,613) | (46,129) | (49,577) | (48,439) | (53,048) | (55,277) | ||
| Gross profit: | 73,043 | 67,748 | 66,401 | 66,488 | 65,670 | 47,526 | ||
| Operating expenses | (68,344) | (59,203) | (60,387) | (61,968) | (60,657) | (57,464) | ||
| Operating income (loss): | 4,699 | 8,545 | 6,014 | 4,520 | 5,013 | (9,938) | ||
| Nonoperating income (expense) | (1,069) | (1,048) | (651) | (1,656) | 1,326 | (947) | ||
| Gain (loss), foreign currency transaction, before tax | (568) | 11 | (731) | 273 | ||||
| Other nonoperating expense | (229) | (108) | (162) | (88) | ||||
| Interest and debt expense | (217) | (332) | (556) | (766) | (856) | (1,107) | ||
| Other undisclosed income from continuing operations before equity method investments, income taxes | 1,872 | 556 | 766 | 856 | 1,107 | |||
| Income (loss) from continuing operations before equity method investments, income taxes: | 5,285 | 7,165 | 5,363 | 2,864 | 6,339 | (10,885) | ||
| Other undisclosed income (loss) from continuing operations before income taxes | (1,655) | 332 | ||||||
| Income (loss) from continuing operations before income taxes: | 3,630 | 7,497 | 5,363 | 2,864 | 6,339 | (10,885) | ||
| Income tax expense (benefit) | (1,886) | (1,924) | (1,899) | (468) | (1,136) | 1,569 | ||
| Income (loss) from continuing operations: | 1,744 | 5,573 | 3,464 | 2,396 | 5,203 | (9,316) | ||
| Income (loss) before gain (loss) on sale of properties: | 1,744 | 5,573 | 3,464 | 2,396 | 5,203 | (9,316) | ||
| Net income (loss) available to common stockholders, diluted: | 1,744 | 5,573 | 3,464 | 2,396 | 5,203 | (9,316) | ||
Comprehensive Income ($ in thousands)Annual | Quarterly
| 3/31/2022 Q1 | 12/31/2021 Q4 | 9/30/2021 Q3 | 6/30/2021 Q2 | 3/31/2021 Q1 | 12/31/2020 Q4 | 9/30/2020 Q3 | ||
|---|---|---|---|---|---|---|---|---|
| Net income (loss): | 1,744 | 5,573 | 3,464 | 2,396 | 5,203 | (9,316) | ||
| Other comprehensive income (loss) | (2,796) | (3,517) | 2,309 | (6,426) | 7,261 | 6,983 | ||
| Comprehensive income (loss), net of tax, attributable to parent: | (1,052) | 2,056 | 5,773 | (4,030) | 12,464 | (2,333) | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.